These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33277031)

  • 1. Randomized trials, observational studies, and the illusive search for the source of truth.
    Gaudino M; Bagiella E; Chang HL; Kurlansky P
    J Thorac Cardiovasc Surg; 2022 Feb; 163(2):757-762. PubMed ID: 33277031
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there a difference between applicability and generalisability?
    Tugwell P; Knottnerus A
    J Clin Epidemiol; 2020 Mar; 119():A5-A7. PubMed ID: 32130940
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized trials analyzed as observational studies.
    Hernán MA; Hernández-Díaz S; Robins JM
    Ann Intern Med; 2013 Oct; 159(8):560-2. PubMed ID: 24018844
    [No Abstract]   [Full Text] [Related]  

  • 4. [Not Available].
    Giulio Formoso, per l'Associazione Alessandro Liberati - Network italiano Cochrane
    Recenti Prog Med; 2019 Nov; 110(11):524-525. PubMed ID: 31808432
    [No Abstract]   [Full Text] [Related]  

  • 5. Observational studies: why are they so important?
    Mariani AW; Pêgo-Fernandes PM
    Sao Paulo Med J; 2014; 132(1):1-2. PubMed ID: 24474072
    [No Abstract]   [Full Text] [Related]  

  • 6. [Not Available].
    Buzzetti R
    Recenti Prog Med; 2019 Nov; 110(11):531. PubMed ID: 31808436
    [No Abstract]   [Full Text] [Related]  

  • 7. Benchmarking Controlled Trial--a novel concept covering all observational effectiveness studies.
    Malmivaara A
    Ann Med; 2015 Jun; 47(4):332-40. PubMed ID: 25965700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why do we continue to adopt medical practices based on pathophysiology alone when we should be insisting on clinical trials?
    Prasad V; Ho N
    J Clin Epidemiol; 2014 Apr; 67(4):361-3. PubMed ID: 24581292
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized  Controlled Trials Versus Real-World Data in the COVID-19 Era: A False Narrative.
    Lyman GH; Kuderer NM
    Cancer Invest; 2020 Nov; 38(10):537-542. PubMed ID: 33090883
    [No Abstract]   [Full Text] [Related]  

  • 10. Choosing wisely between randomized controlled trials and observational designs in studies about interventions.
    Ferreira JC; Patino CM
    J Bras Pneumol; 2016; 42(3):165. PubMed ID: 27383927
    [No Abstract]   [Full Text] [Related]  

  • 11. Observational studies using propensity score analysis underestimated the effect sizes in critical care medicine.
    Zhang Z; Ni H; Xu X
    J Clin Epidemiol; 2014 Aug; 67(8):932-9. PubMed ID: 24774469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study Design in Neurosurgical Research: Considerations for Observational and Experimental Cohort Studies.
    Louie CE; D'Agostino E; Woods A; Ryken T
    Neurosurgery; 2020 Jan; 86(1):14-18. PubMed ID: 31552423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized clinical trials in surgery: why do we need them?
    Balch CM
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):241-2. PubMed ID: 16872941
    [No Abstract]   [Full Text] [Related]  

  • 14. Population Diversity Challenge the External Validity of the European Randomized Controlled Trials Comparing Laparoscopic Gastric Bypass and Sleeve Gastrectomy.
    Mazzini GS; Khoraki J; Browning MG; Pessoa BM; Wolfe LG; Campos GM
    Obes Surg; 2020 Mar; 30(3):992-1000. PubMed ID: 31768868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.
    Hernán MA; Robins JM
    Am J Epidemiol; 2016 Apr; 183(8):758-64. PubMed ID: 26994063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness?
    Slattery J; Kurz X
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1336-1340. PubMed ID: 32301230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propensity scores: a tool to help quantify treatment effects in observational studies.
    Patino CM; Ferreira JC
    J Bras Pneumol; 2017; 43(2):86. PubMed ID: 28538773
    [No Abstract]   [Full Text] [Related]  

  • 18. How They Did It: Increasing Transparency for Randomized Trial Methods.
    Brubaker L
    Female Pelvic Med Reconstr Surg; 2016; 22(4):181. PubMed ID: 27337409
    [No Abstract]   [Full Text] [Related]  

  • 19. Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review.
    Vonbank A; Drexel H; Agewall S; Lewis BS; Dopheide JF; Kjeldsen K; Ceconi C; Savarese G; Rosano G; Wassmann S; Niessner A; Schmidt TA; Saely CH; Baumgartner I; Tamargo J
    Eur Heart J Cardiovasc Pharmacother; 2018 Oct; 4(4):230-236. PubMed ID: 30099530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement.
    Visvanathan K; Levit LA; Raghavan D; Hudis CA; Wong S; Dueck A; Lyman GH
    J Clin Oncol; 2017 Jun; 35(16):1845-1854. PubMed ID: 28358653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.